Biogen Europe Patient Portal Sma Account Login Page List

Created at: 2021-12-02 05:44:33
Questioner General

Looking to visit biogen europe patient portal sma to get your lab reports, appontment or any other health records.
But due to certain unavoidable reasons you are unable to find its correct link?
Just keep calm , we have listed all

Acess your Biogen Europe Patient Portal Sma from below list.

Last Updated: 2021-12-02 05:44:33
Answer By: Prof. Rosella Hirthe III

1. Spinal Muscular Atrophy - Biogen

https://www.biogen.com/en_us/spinal-muscular-atrophy.html

Spinal Muscular Atrophy. Spinal muscular atrophy (SMA) is a genetic, progressive, and often terminal rare disease that affects an individual's ability to walk, eat, and, ultimately, breathe. Debilitating and often fatal, SMA affects approximately one in 10,000 live births and is a leading genetic cause of death among infants.
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Emory Cassin

2. SMA Europe

https://www.sma-europe.eu/

Dr. Christian Simon has been granted an SMA Europe award to investigate how proprioceptive synapses degenerate and how their function could be improved, which may aid the discovery of novel therapeutic strategies in humans. Background. Muscle shrinkage and paralysis are the most prominent physical features of SMA patients.About Us‧About SMA‧SMA Research‧Advocacy‧NBS Alliance‧Our Projects
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Prof. Darrin Adams II

3. Biogen | Home

https://www.biogen.com/

Biogen Digital Health aspires to transform patients' lives and Biogen by making personalized & digital medicine in neuroscience a reality. Biogen marks one-year anniversary of $250 million, 20-year commitment to accelerate action on the greatest challenges of our time: climate, health and equity. Biogen and Eisai receive FDA accelerated ...
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Dr. Keanu Rippin

4. Trial of Spinraza at High Dose in SMA Patients Who Used ...

https://smanewstoday.com/news-posts/2021/09/17/high-dose-spinraza-trial-sma-patients-using-evrysdi/

Biogen plans to launch a Phase 3b trial into the safety and efficacy of a higher dose of Spinraza (nusinersen) in children, teenagers, and adults with later-onset spinal muscular atrophy (SMA) previously treated with Evrysdi (risdiplam). The trial, to be called ASCEND and to run for roughly 2.5 years, expects to enroll up to 135 patients, ages ...
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Neoma Mertz

5. SMA Treatment Spinraza Approved in Europe to Treat Disease ...

https://smanewstoday.com/news-posts/2017/06/01/spinraza-approved-in-europe-to-treat-sma-types-1-to-3/

Spinal muscular atrophy (SMA) patients in the European Union will soon have access to Spinraza (nusinersen), the first treatment approved for people with this disease and one able to treat almost all types of SMA.. The European Commission announced late Thursday that it had approved Spinraza, marketed by Biogen, to treat SMA in both children and adults.
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Buck Schimmel

6. Barcelona 2022 | SMA Europe

https://www.sma-europe.eu/sma-research/our-congresses/barcelona-2022/

SMA Europe will be hosting its 3rd international scientific and clinical congress on SMA 9th - 11th February 2022 Barcelona, Spain. Through our dedicated website, you will find more information on our programme, the venue and very importantly, the portal for registration and abstract submission. Some important dates
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Stephany Lynch

7. BIOGEN Optimistic for Rapid and Broad Patient Access ...

https://www.prnewswire.co.uk/news-releases/biogen-optimistic-for-rapid-and-broad-patient-access-following-invitation-to-submit-spinraza-nusinersen-670471453.html

Following the assessment of nusinersen in patients affected by SMA, results from the ENDEAR end of study analysis indicate that some infants achieved motor milestones including full head control ...
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Ms. Everette Marvin MD

8. In UK and Ireland, SMA Patients Demand Reimbursement for ...

https://smanewstoday.com/news-posts/2019/03/06/in-uk-and-ireland-sma-patients-demand-reimbursement-for-spinraza/

Yet Biogen's Expanded Access Program, which enabled patients to obtain the expensive drug for free, closed in November, with only 80 or so patients benefiting from it, he said. In Scotland, he said, "Spinraza will now be refunded retroactively, while England, Wales and Northern Ireland are still waiting.
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Isabell Rath

9. Poor Spinraza Adherence in SMA Leads to More Illness ...

https://smanewstoday.com/news-posts/2021/11/17/poor-spinraza-adherence-sma-leads-more-illness-healthcare-costs/

A total of 62 patients with SMA type 1, 94 patients with SMA type 2, and 462 patients with SMA type 3 were included in the analysis. The patients' mean ages ranged from 0.67, or younger than 1 year, for some type 1 patients, to 17.53 years, for certain type 3 patients.
> More Info
Last Updated: 2021-12-02 05:44:33
Answer By: Dr. Antonio Hilpert III

10. SMA Europe | LinkedIn

https://www.linkedin.com/company/sma-europe

SMA Europe is an umbrella organisation, founded in 2006, which includes patient and research organisations from 22 countries across Europe. SMA Europe's aims are to provide a framework to ...
> More Info

FAQ

I’m a new visitor to biogen europe patient portal sma. How do I login?
As you explore biogen europe patient portal sma web sites you may encounter content that is only accessible to biogen europe patient portal sma Members and registered visitors. Should you encounter this type of content, a login screen displays and you need to create an account. Upon completing the registration process you will be able to login using the email and password you entered during account creation. For return visits enter your Username and Password in the login box.

I’m a member of biogen europe patient portal sma. How do I login?
The first time you login, enter your Username and Password in the login box which is located throughout the biogen europe patient portal sma site. If you cannot remember your Username or Password use the Forgot Username or Forgot Password links to receive a reset email to your primary email address.

How can I contact the support ?
To contact the biogen europe patient portal sma support, please visit our contact us page. Raise a ticket or mail us on our official id.

I forgot my biogen europe patient portal sma password. How do I obtain it?
Ans: First Go to biogen europe patient portal sma login page and then click on forgot password link. Enter your username or mail id to get the password reset link.

I’m a new visitor to biogen europe patient portal sma. How do I login?
As you explore biogen europe patient portal sma web sites you may encounter content that is only accessible to biogen europe patient portal sma Members and registered visitors. Should you encounter this type of content, a login screen displays and you need to create an account. Upon completing the registration process you will be able to login using the email and password you entered during account creation. For return visits enter your Username and Password in the login box.

Can I Submit my feedback related to biogen europe patient portal sma Login?
Yes, you are always welcome to share your experience with us. It helps us to improve the user experience. Please share your experience with biogen europe patient portal sma Login or any suggestion with us via email, we really appreciate it.

Related Post

Troubleshoot:

How to get in touch with the Customer Care executives of the biogen europe patient portal sma?


 Step 1.First and foremost, you need to do visit the official page of biogen europe patient portal sma.
Step 2.Enter the login credentials of your account and click on the login button.
Step 3.You can reach out to the customer care executives on the given helpline number without wasting a minute and get your login related queries resolved within minutes.